vtioВестник трансплантологии и искусственных органовRussian Journal of Transplantology and Artificial Organs1995-1191Academician V.I.Shumakov National Medical Research Center of Transplantology and Artificial Organs", Ministry of Health of the Russian Federation10.15825/1995-1191-2019-4-143-146vtio-1116Research ArticleОБЗОРЫ ЛИТЕРАТУРЫLITERATURE REVIEWSСовременное состояние проблемы и результаты ex vivo перфузии донорских сердецCurrent state of the problem and results of ex vivo perfusion of donor heartsЖульковМ. О.ZhulkovM. O.

Центр хирургии аорты, коронарных и периферических артерий.

Жульков Максим Олегович.

630055, Новосибирск, ул. Речкуновская, д. 15.Тел. (906) 909-05-05

Center for Surgery of the Aorta, Coronary and Peripheral Arteries.

Zhulkov Maxim Olegovich

15, Rechkunovskaya str., Novosibirsk, 630055.Tel. (906) 909-05-05

maks.zhulkov.92@mail.ruФомичевА. В.FomichevA. V.

Центр хирургии аорты, коронарных и периферических артерий.

Новосибирск

Center for Surgery of the Aorta, Coronary and Peripheral Arteries.

Novosibirsk

АльсовС. А.AlsovS. A.

Центр хирургии аорты, коронарных и периферических артерий.

Новосибирск

Center for Surgery of the Aorta, Coronary and Peripheral Arteries.

Novosibirsk

КливерЕ. Н.CleaverE. N.

Центр хирургии аорты, коронарных и периферических артерий.

Новосибирск

Center for Surgery of the Aorta, Coronary and Peripheral Arteries.

Novosibirsk

ЧернявскийА. М.ChernyavskyA. M.

Центр хирургии аорты, коронарных и периферических артерий.

Новосибирск

Center for Surgery of the Aorta, Coronary and Peripheral Arteries.

Novosibirsk

ФГБУ «Национальный медицинский исследовательский центр имени академика Е.Н. Мешалкина» Минздрава РоссииРоссияMeshalkin National Medical Research CenterRussian Federation201902022020214143146Copyright © Жульков М.О., Фомичев А.В., Альсов С.А., Кливер Е.Н., Чернявский А.М., 20202020Жульков М.О., Фомичев А.В., Альсов С.А., Кливер Е.Н., Чернявский А.М.Zhulkov M.O., Fomichev A.V., Alsov S.A., Cleaver E.N., Chernyavsky A.M.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.transpl.ru/vtio/article/view/1116

Больные с терминальной сердечной недостаточностью, рефрактерной к медикаментозной терапии, являются тяжелой категорией кардиологических больных. Многочисленные исследования доказали наибольшую эффективность трансплантации сердца по сравнению с другими методами лечения терминальной стадии хронической сердечной недостаточности. Однако несмотря на десятилетия развития трансплантологии, вопрос нехватки донорских органов остается открытым. Единственным способом сократить нехватку донорских органов является использование доноров с расширенными критериями, что требует использования самых последних технологий в области реанимации и кондиционировании органов.

Patients with drug refractory end-stage heart failure fall into the severe category of cardiological patients. Numerous studies have shown the superior efficacy of heart transplantation over other treatments for end-stage chronic heart failure. However, despite decades of achievements in transplantology, shortage of donor organs remains a pressing and unresolved issue. The only way to reduce shortage of donor organs is to use donors with advanced criteria, which requires the use of latest technologies in organ resuscitation and conditioning.

сердечная недостаточностьтрансплантация сердцаперфузия ex vivoheart failureheart transplantationex vivo perfusionReferencesWorld Health Organization. World Health Statistics 2016: Monitoring Health for the SDGs Annex B: Tables of Health Statistics by Country, WHO Region and Globally [Internet]. 2016.World Health Organization. World Health Statistics 2016: Monitoring Health for the SDGs Annex B: Tables of Health Statistics by Country, WHO Region and Globally [Internet]. 2016.Heidenreich PA, Albert NM, Allen LA, Bluemke DA, Butler J, Fonarow GC et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail. 2013; 6: 606–619.Heidenreich PA, Albert NM, Allen LA, Bluemke DA, Butler J, Fonarow GC et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail. 2013; 6: 606–619.Messer S, Ardehali A, Tsui S. Normothermic donor heart perfusion: current clinical experience and the future. Transplant International. 2015; 28 (6): 634–642.Messer S, Ardehali A, Tsui S. Normothermic donor heart perfusion: current clinical experience and the future. Transplant International. 2015; 28 (6): 634–642.Blood N.H.S. Transplant. Organ Donation and Transplantation activity figures for the UK as at 12 April 2013. – 2014.Blood N.H.S. Transplant. Organ Donation and Transplantation activity figures for the UK as at 12 April 2013. – 2014.Canadian Institute for Health Information. Canadian Organ Replacement Register Annual Report: Treatment of End-Stage Organ Failure in Canada, 2004 to 2013. Ottawa, ON: Canadian Institute for Health Information; (2015).Canadian Institute for Health Information. Canadian Organ Replacement Register Annual Report: Treatment of End-Stage Organ Failure in Canada, 2004 to 2013. Ottawa, ON: Canadian Institute for Health Information; (2015).Barnard CN. Human cardiac transplant: An interim report of a successful operation performed at Groote Schuur Hospital, Cape Town. South African Medical Journal. 1967; 41 (48): 1271–1274.Barnard CN. Human cardiac transplant: An interim report of a successful operation performed at Groote Schuur Hospital, Cape Town. South African Medical Journal. 1967; 41 (48): 1271–1274.Rudge C, Matesanz R, Delmonico FL, Chapman J. International practices of organ donation. Br J Anaesthesia. 2012; 108 (S1): i48–i55.Rudge C, Matesanz R, Delmonico FL, Chapman J. International practices of organ donation. Br J Anaesthesia. 2012; 108 (S1): i48–i55.Citerio G, Cypel M, Dobb GJ et al. Organ donation in adults: a critical care perspective. Intensive Care Med. 2016; 42: 305–315.Citerio G, Cypel M, Dobb GJ et al. Organ donation in adults: a critical care perspective. Intensive Care Med. 2016; 42: 305–315.Costanzo MR, Dipchand A, Starling R, Anderson A, Chan M, Desai S et al. Task Force 1: peri-operative care of the heart transplant patient. In: the International Society of Heart and Lung Transplantation guidelines for the care of heart transplant recipients. J Heart Lung Transplant. 2010 Aug; 29 (8): 915–926.Costanzo MR, Dipchand A, Starling R, Anderson A, Chan M, Desai S et al. Task Force 1: peri-operative care of the heart transplant patient. In: the International Society of Heart and Lung Transplantation guidelines for the care of heart transplant recipients. J Heart Lung Transplant. 2010 Aug; 29 (8): 915–926.Banner NR, Thomas HL, Curnow E et al. The importance of cold and warm cardiac ischemic for survival after heart transplantation. Steering Group of the United Kingdom Cardiothoracic.Banner NR, Thomas HL, Curnow E et al. The importance of cold and warm cardiac ischemic for survival after heart transplantation. Steering Group of the United Kingdom Cardiothoracic.Transplant Audit. Transplantation. 2008; 86: 542–547.Transplant Audit. Transplantation. 2008; 86: 542–547.Russo MJ, Iribarne A, Hong KN et al. Factors associated with primary allograft failure after heart transplantation. Transplantation. 2010; 90: 444–450.Russo MJ, Iribarne A, Hong KN et al. Factors associated with primary allograft failure after heart transplantation. Transplantation. 2010; 90: 444–450.Hertz MI, Aurora P, Christie JD et al. Scientific Registry of the International Society for Heart and Lung Transplantation: introduction to the 2009 annual reports. J Heart Lung Transplant. 2009; 28: 989–992.Hertz MI, Aurora P, Christie JD et al. Scientific Registry of the International Society for Heart and Lung Transplantation: introduction to the 2009 annual reports. J Heart Lung Transplant. 2009; 28: 989–992.Schnitzler MA, Hauptman PJ, Takemoto SK et al. The impact of cold ischaemia time on life year benefit of heart transplantation. Am J Transplant. 2006; 6: 382.Schnitzler MA, Hauptman PJ, Takemoto SK et al. The impact of cold ischaemia time on life year benefit of heart transplantation. Am J Transplant. 2006; 6: 382.Kobashigawa J, Zuckermann A, Macdonald P et al. Consensus Conference Participants. Report from a consensus conference on primary graft dysfunction after cardiac transplantation. J Heart Lung Transplant. 2014; 33: 327–340.Kobashigawa J, Zuckermann A, Macdonald P et al. Consensus Conference Participants. Report from a consensus conference on primary graft dysfunction after cardiac transplantation. J Heart Lung Transplant. 2014; 33: 327–340.Sáez DG et al. Evaluation of the organ care system in heart transplantation with an adverse donor/recipient profile. The Annals of thoracic surgery. 2014; 98 (6): 2099–2106.Sáez DG et al. Evaluation of the organ care system in heart transplantation with an adverse donor/recipient profile. The Annals of thoracic surgery. 2014; 98 (6): 2099–2106.Del Riozz DF, Menkis AH, Pflugfelder PW, Novick RJ, McKenzie FN, Boyd WD, Kostul WJ. The role of donor age and ischemic time on survival following orthotopic heart transplantation. J Heart Lung Transplant. 1999; 18: 310–319.Del Riozz DF, Menkis AH, Pflugfelder PW, Novick RJ, McKenzie FN, Boyd WD, Kostul WJ. The role of donor age and ischemic time on survival following orthotopic heart transplantation. J Heart Lung Transplant. 1999; 18: 310–319.Iyer A, Gao L, Doyle A et al. Normothermic ex vivo perfusion provides superior preservation and enables viability assessment of hearts from DCD donors. Am J Transplant. 2015; 15: 371–380.Iyer A, Gao L, Doyle A et al. Normothermic ex vivo perfusion provides superior preservation and enables viability assessment of hearts from DCD donors. Am J Transplant. 2015; 15: 371–380.Zaroff JG, Rosengard BR, Armstrong WF et al. Consensus conference report: maximizing use of organs recovered from the cadaver donor: cardiac recommendations: March 28–29, 2001, Crystal City, Va. Circulation 2002; 106: 836–841.Zaroff JG, Rosengard BR, Armstrong WF et al. Consensus conference report: maximizing use of organs recovered from the cadaver donor: cardiac recommendations: March 28–29, 2001, Crystal City, Va. Circulation 2002; 106: 836–841.Costanzo MR, Dipchand A, Starling R et al. The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. J Heart Lung Transplant. 2010; 29: 914–956.Costanzo MR, Dipchand A, Starling R et al. The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. J Heart Lung Transplant. 2010; 29: 914–956.Esmailian F et al. The PROCEED II international heart transplant trial with the organ care system technology (OCS). The Journal of Heart and Lung Transplantation. 2013; 32 (4): S95–S96.Esmailian F et al. The PROCEED II international heart transplant trial with the organ care system technology (OCS). The Journal of Heart and Lung Transplantation. 2013; 32 (4): S95–S96.Cypel M, Yeung JC, Machuca T et al. Experience with the first 50 ex vivo lung perfusions in clinical transplantation. J Thorac Cardiovasc Surg. 2012; 144: 1200–1206.Cypel M, Yeung JC, Machuca T et al. Experience with the first 50 ex vivo lung perfusions in clinical transplantation. J Thorac Cardiovasc Surg. 2012; 144: 1200–1206.Ghodsizad A, Bordel V, Ungerer M et al. Ex vivo coronary angiography of a donor heart in the organ care system. Heart Surg Forum. 2012; 15: E161–3.Ghodsizad A, Bordel V, Ungerer M et al. Ex vivo coronary angiography of a donor heart in the organ care system. Heart Surg Forum. 2012; 15: E161–3.Scholar T. The Chironian Vol. 22 No. – 1960.Scholar T. The Chironian Vol. 22 No. – 1960.Quader MA, Wolfe LG, Kasirajan V. Heart transplantation outcomes from cardiac arrest-resuscitated donors. Heart Lung Transplant. 2013; 32: 1090–1095.Quader MA, Wolfe LG, Kasirajan V. Heart transplantation outcomes from cardiac arrest-resuscitated donors. Heart Lung Transplant. 2013; 32: 1090–1095.Tikkanen JM, Cypel M, Machuca TN et al. Functional outcomes and quality of life after normothermic ex vivo lung perfusion lung transplantation. J Heart Lung Transplant. 2015; 34: 547–556.Tikkanen JM, Cypel M, Machuca TN et al. Functional outcomes and quality of life after normothermic ex vivo lung perfusion lung transplantation. J Heart Lung Transplant. 2015; 34: 547–556.Page A et al. Early outcomes from DCD heart transplantation: a single centre experience. The Journal of Heart and Lung Transplantation. 2018; 37 (4): S13–S14.Page A et al. Early outcomes from DCD heart transplantation: a single centre experience. The Journal of Heart and Lung Transplantation. 2018; 37 (4): S13–S14.The National Institute for Health and Care Excellence. OCS Heart System for Heart Transplant, Medtech Innovation Briefing. https://www.nice.org.uk/advice/mib86/resources/ocs-heart-system-for-heart-transplantpdf63499411285189 (30 August 2018, date last accessed).The National Institute for Health and Care Excellence. OCS Heart System for Heart Transplant, Medtech Innovation Briefing. https://www.nice.org.uk/advice/mib86/resources/ocs-heart-system-for-heart-transplantpdf63499411285189 (30 August 2018, date last accessed).Messer S, Page A, Axell R, Berman M, Hernández-Sánchez J, Colah S et al. Outcome after heart transplantation from donation after circulatorydetermined death donors. J Heart Lung Transplant. 2017; 36: 1311–1318.Messer S, Page A, Axell R, Berman M, Hernández-Sánchez J, Colah S et al. Outcome after heart transplantation from donation after circulatorydetermined death donors. J Heart Lung Transplant. 2017; 36: 1311–1318.

The authors declare that there are no conflicts of interest present.